This story is from the CurrentWire archive. Coverage details reflect the last time it was updated.
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth markets Highlights Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials Includes a 60,000 sq. ft. GLP bioanalytical lab in Austin; […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 23 minutes later, on .
Filed under Health · International · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: Acquire Clinical Pharmacology Unit (none), Bioanalytical Laboratory Operations (none), Worldwide Clinical Trials (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.